greeksoup/ stock research
Stock research / United States / DSGN / Planned sales

Design Therapeutics, Inc. planned insider sales

In the last twelve months insiders at Design Therapeutics, Inc. filed 3 Form 144 notices of planned sales, 1.2 million shares worth $8.1 million at the time of filing, from 1 seller. The latest, filed 18 November 2025: Logos Global Master Fund LP (director), 120,000 shares worth $891,600, planned for around 18 November 2025 through BTIG, LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
18 November 2025Logos Global Master Fund LPDirector120,000$891,60018 November 2025No matching Form 4 saleBTIG, LLCopen marketForm 144
14 November 2025Logos Global Master Fund LPDirector620,000$4.4 million14 November 2025No matching Form 4 saleBTIG, LLCopen marketForm 144
7 November 2025Logos Global Master Fund LPDirector415,000$2.9 million7 November 2025No matching Form 4 saleBTIG, LLCOpen marketForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?